Anaphylaxis to tocilizumab in patients with rheumatic disease.
Nam SH, Lim DH, Heo HM, Oh JS, Kwon HS, Kim TB, Ahn SM, Hong S, Lee CK, Yoo B, Kim YG.
Nam SH, et al. Among authors: kim tb, kim yg.
Immunotherapy. 2021 Dec;13(18):1483-1489. doi: 10.2217/imt-2020-0307. Epub 2021 Oct 18.
Immunotherapy. 2021.
PMID: 34657472
Clinical Trial.